(Q52108893)

22 April 2018

title

Patterns of associations of clinical features in neurofibromatosis 1 (NF1). (English)

1 reference

22 April 2018

author

Gareth Evans

series ordinal

2

1 reference

22 April 2018

Jan M Friedman

object named as

Jan M Friedman

series ordinal

3

0 references

author name string

Jacek Szudek

series ordinal

1

1 reference

22 April 2018

publication date

20 December 2002

1 reference

22 April 2018

published in

Human Genetics

1 reference

22 April 2018

volume

112

1 reference

22 April 2018

issue

3

1 reference

22 April 2018

page(s)

289-297

1 reference

22 April 2018

National Neurofibromatosis Foundation International Database.

cites work

1 reference

12 December 2020

An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.

1 reference

12 December 2020

Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes

1 reference

12 December 2020

An association between optic glioma and other tumours of the central nervous system in neurofibromatosis type 1.

1 reference

12 December 2020

Iris (Lisch) nodules in neurofibromatosis

1 reference

12 December 2020

Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1.

1 reference

12 December 2020

Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations

1 reference

12 December 2020

Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients.

1 reference

12 December 2020

Familial neurofibromatosis 1 microdeletions: cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata

1 reference

12 December 2020

The regulation of normal and abnormal neural crest cell development

1 reference

12 December 2020

NCHS growth curves for children birth-18 years. United States

1 reference

12 December 2020

Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes

1 reference

12 December 2020

MRI morphometric analysis and neuropsychological function in patients with neurofibromatosis.

1 reference

12 December 2020

The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

1 reference

12 December 2020

Melanin synthesis pathways in the pathogenesis of neurofibromatosis

1 reference

12 December 2020

Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1

1 reference

12 December 2020

Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference

1 reference

12 December 2020

Watson syndrome: is it a subtype of type 1 neurofibromatosis?

1 reference

12 December 2020

Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children.

1 reference

12 December 2020

A search for evidence of somatic mutations in the NF1 gene.

1 reference

12 December 2020

Associations of clinical features in neurofibromatosis 1 (NF1).

1 reference

12 December 2020

Iris nodules in von Recklinghausen's Neurofibromatosis. Electron microscopic confirmation of their melanocytic origin

1 reference

12 December 2020

Brain morphometric analysis in neurofibromatosis 1

1 reference

12 December 2020

NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes.

1 reference

12 December 2020

A clinical study of type 1 neurofibromatosis in north west England

1 reference

12 December 2020

Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation

1 reference

12 December 2020

10.1007/S00439-002-0871-7

Identifiers

DOI

1 reference

22 April 2018

1 reference

22 April 2018